Broparestrol

This classification denotes a therapeutic estrogen with the molecular formula C22H19Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7U06D381UQ, chemically known as 2-brom-1-(4-ethylphenyl)-1,2-diphenylethylen but generally known as broparestrol, which bears US NIH Compound Identifier 3032769. European Medicines Agency schedules Broparestrol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05926MIG. The term BROPARESTROL is an International Non-Proprietary Name. BROPARESTROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, BROPARESTROL remains the US FDA Preferred Term for this commodity. Broparestrol bears US NLM identifiers UMLS ID C0054148 and NCI Concept Code C76995. SMILES: Br/C(=C(/c1ccc(CC)cc1)c1ccccc1)c1ccccc1.